- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Nykode Therapeutics
Market Cap: NOK 539.5m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.65
7D
5.0%
1Y
-64.4%
Lytix Biopharma
Market Cap: NOK 491.5m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 7.20
7D
2.6%
1Y
-1.9%
Navamedic
Market Cap: NOK 383.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.70
7D
3.3%
1Y
-29.3%